Print

Purpose

This study aims to test the feasibility and acceptability of a remotely delivered cue-based treatment intervention to promote smoking cessation among people who smoke lightly or non-daily. Secondary objectives include assessing preliminary efficacy on cessation and examining cue reactivity. Participants will be randomized to CBT only or CBT + cue-based treatment, with assessments at baseline, end-of-treatment, 6 months, and 12 months.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 - Able to read and understand English or Spanish - Smoke 1-10 cigarettes/day on at least 4 days of the past two weeks for the last year - Willing to try quitting in next 30 days - Access to cell phone with texting capabilities

Exclusion Criteria

  • Current participation in another smoking cessation study - Unable to provide consent - Refusal to abstain from e-cigarettes or other tobacco products - Use of medications affecting smoking cessation (e.g., Chantix, Wellbutrin)

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
CBT only 		CBT delivered via telehealth sessions and supportive text messages.
  • Behavioral: Cognitive Behavioral Therapy (CBT)
    CBT delivered via telehealth sessions and supportive text messages.
Experimental
CBT + Cue-based treatment 		CBT plus cue-based treatment includes exposure to smoking-related cues and coping strategies.
  • Behavioral: Cognitive Behavioral Therapy (CBT)
    CBT delivered via telehealth sessions and supportive text messages.
  • Behavioral: Cue-based treatment intervention
    Cue-based treatment includes exposure to smoking-related cues and coping strategies.

Recruiting Locations

Duke University
Durham, North Carolina 27701
Contact:
Laura Fish, PhD
9196813820
laura.fish@duke.edu

More Details

Status
Recruiting
Sponsor
Duke University

Study Contact

Laura Fish, PhD
919-681-3820
laura.fish@duke.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.